Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
Fuse
Y
Y
Fuse
K
K
D000933:Antifibrinolytic Agents / Q000032:analysis*; D000990:Antithrombin III / Q000032:analysis*; D001724:Birth Weight; D005260:Female; D005312:Fetal Blood / Q000032:analysis*; D005341:Fibrinolysin / Q000032:analysis*; D006470:Hemorrhage / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D010958:Plasminogen / Q000032:analysis*; D049590:Postpartum Period; D011247:Pregnancy; D011644:Puerperal Disorders / Q000097:blood; D000979:alpha-2-Antiplasmin
D000933:Antifibrinolytic Agents; D000979:alpha-2-Antiplasmin; C037742:plasmin-plasmin inhibitor complex; D000990:Antithrombin III; D010958:Plasminogen; D005341:Fibrinolysin